Author:
Jiang Dingyi,Xu Yunyun,Chen Yunwang,Jiang Jiahong,Wang Mingxing,Yang Min,Chen Zheling,Yang Liu
Funder
National Natural Science Foundation of China
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM;An;Arch. Surg.,2009
2. Targeted therapy: Apatinib - new third-line option for refractory gastric or GEJ cancer;Aoyama;Nat. Rev. Clin. Oncol.,2016
3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010
4. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0;Chen;J. Am. Acad. Dermatol.,2012
5. Annual report on status of cancer in China, 2011;Chen;Chin. J. Cancer Res.,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献